Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Tvardi Therapeutics, Inc.(TVRD US)

$1.38-0.032.13%(Market Open · 16:20:16 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Tvardi Therapeutics, Inc.(TVRD US)

$1.38-0.032.13%(Market Open · 16:20:16 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

TVRD US

TVRD US

Chronological SEC Filings

Chronological SEC Filings

Non-Ownership Filings(315)

10-QQ2ended 30 Jun 202614 Aug
8-KResults of Operations and Financial Condition14 Aug
8-KRegulation FD Disclosure30 Jul
8-KOther Events17 Jul
424B5Prospectus filing (Rule 424(b)(5))17 Jul
8-KRegulation FD Disclosure7 Jul
8-KSubmission of Matters to a Vote of Security Holders11 Jun
EFFECTNotice of effectiveness14 May
EFFECTNotice of effectiveness13 May
POS AMPost-effective amendment (unspecified)8 May
CORRESPFiling review correspondence8 May
10-QQ1ended 31 Mar 20268 May
8-KResults of Operations and Financial Condition8 May
S-3Registration statement (primary offering)1 May
ARSAnnual report to security holders23 Apr
DEFA14ADefinitive additional materials23 Apr
DEF 14ADefinitive proxy statement23 Apr
S-8Registration statement (employee benefit plan)1 Apr
POS EXPost-effective amendment (exchange offer)1 Apr
424B3Prospectus filing (Rule 424(b)(3))1 Apr

Ownership Filings(477)

Form 4Shiff Susan Ph.D.11 Jun
Form 4Smith Cynthia11 Jun
Form 4Shah Sujal11 Jun
Form 4HALL WALLACE L JR11 Jun
Form 4WYZGA MICHAEL S11 Jun
SC 13G/ATvardi Therapeutics, Inc.17 Feb
Form 4O'Brien Stephen Paul2 Feb
Form 4Conn Avi Daniel2 Feb
Form 4Kauh John Saewook M.D.2 Feb
Form 4Alibhai Imran Nizamudin2 Feb
Form 4O'Brien Stephen Paul18 Dec 2025
Form 4Kauh John Saewook M.D.18 Dec 2025
Form 4Conn Avi Daniel18 Dec 2025
Form 4Alibhai Imran Nizamudin18 Dec 2025
SC 13G/ATvardi Therapeutics, Inc.14 Nov 2025
SC 13GTvardi Therapeutics, Inc.14 Aug 2025
SC 13GTvardi Therapeutics, Inc.8 Aug 2025
Form 4Tweardy Samuel David5 Aug 2025
SC 13G/ATvardi Therapeutics, Inc.5 Aug 2025
SC 13GTvardi Therapeutics, Inc.2 Jun 2025

Non-Ownership Filings(315)

10-QQ2ended 30 Jun 202614 Aug
8-KResults of Operations and Financial Condition14 Aug
8-KRegulation FD Disclosure30 Jul
8-KOther Events17 Jul
424B5Prospectus filing (Rule 424(b)(5))17 Jul
8-KRegulation FD Disclosure7 Jul
8-KSubmission of Matters to a Vote of Security Holders11 Jun
EFFECTNotice of effectiveness14 May
EFFECTNotice of effectiveness13 May
POS AMPost-effective amendment (unspecified)8 May
CORRESPFiling review correspondence8 May
10-QQ1ended 31 Mar 20268 May
8-KResults of Operations and Financial Condition8 May
S-3Registration statement (primary offering)1 May
ARSAnnual report to security holders23 Apr
DEFA14ADefinitive additional materials23 Apr
DEF 14ADefinitive proxy statement23 Apr
S-8Registration statement (employee benefit plan)1 Apr
POS EXPost-effective amendment (exchange offer)1 Apr
424B3Prospectus filing (Rule 424(b)(3))1 Apr

Ownership Filings(477)

Form 4Shiff Susan Ph.D.11 Jun
Form 4Smith Cynthia11 Jun
Form 4Shah Sujal11 Jun
Form 4HALL WALLACE L JR11 Jun
Form 4WYZGA MICHAEL S11 Jun
SC 13G/ATvardi Therapeutics, Inc.17 Feb
Form 4O'Brien Stephen Paul2 Feb
Form 4Conn Avi Daniel2 Feb
Form 4Kauh John Saewook M.D.2 Feb
Form 4Alibhai Imran Nizamudin2 Feb
Form 4O'Brien Stephen Paul18 Dec 2025
Form 4Kauh John Saewook M.D.18 Dec 2025
Form 4Conn Avi Daniel18 Dec 2025
Form 4Alibhai Imran Nizamudin18 Dec 2025
SC 13G/ATvardi Therapeutics, Inc.14 Nov 2025
SC 13GTvardi Therapeutics, Inc.14 Aug 2025
SC 13GTvardi Therapeutics, Inc.8 Aug 2025
Form 4Tweardy Samuel David5 Aug 2025
SC 13G/ATvardi Therapeutics, Inc.5 Aug 2025
SC 13GTvardi Therapeutics, Inc.2 Jun 2025